Skip to main content
. Author manuscript; available in PMC: 2014 Dec 30.
Published in final edited form as: Obesity (Silver Spring). 2009 Oct 1;18(3):548–554. doi: 10.1038/oby.2009.304

Figure 1.

Figure 1

Change in metabolic syndrome (MetS) score between groups in men and women. Model 1 is adjusted for baseline MetS score, cohort, age, and menopausal hormonal therapy (as appropriate). Model 2 adjusts for the previous covariates as well as baseline body fat (%) and the change in body fat (%). (a) Change in MetS scores between treatment groups in men (n = 179) showed differences between the control group vs. diet (P = 0.04), control group vs. diet plus exercise (P = 0.0002), and exercise vs. diet plus exercise (P = 0.02). Model 2 did not have any differences between groups in men. (b) Changes in scores between treatment groups in women (n = 149) showed differences in control vs. diet (P = 0.045), control vs. exercise (P = 0.02), and control vs. diet plus exercise (P = 0.004). Model 2 did not have any differences between groups in women. Asterisks denote significant differences for the change in percent body fat between treatment groups from baseline to follow-up.